X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in X4 Pharmaceuticals, Inc as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 93
- +3 vs. Q3 2023
- Shares held
- 96.8M
- −15.6M (−13.9%) vs. Q3 2023
- Total value
- $81.2M
- −$41.4M (−33.8%) vs. Q3 2023
- New holders
- 17
- 28 more added
- Sold out
- 14
- 21 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XFOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 89 | $463.0M |
| Q1 2026 | 84 | $388.1M |
| Q4 2025 | 79 | $357.7M |
| Q3 2025 | 42 | $55.3M |
| Q2 2025 | 52 | $5.33M |
| Q1 2025 | 94 | $23.3M |
| Q4 2024 | 90 | $73.2M |
| Q3 2024 | 98 | $67.3M |
| Q2 2024 | 99 | $58.9M |
| Q1 2024 | 98 | $143.2M |
| Q4 2023 | 93 | $81.2M |
| Q3 2023 | 91 | $122.6M |
| Q2 2023 | 96 | $219.1M |
| Q1 2023 | 59 | $53.6M |
| Q4 2022 | 54 | $60.2M |
| Q3 2022 | 59 | $66.9M |
| Q2 2022 | 51 | $15.5M |
| Q1 2022 | 56 | $28.6M |
| Q4 2021 | 52 | $40.2M |
| Q3 2021 | 52 | $85.7M |
| Q2 2021 | 63 | $107.8M |
| Q1 2021 | 61 | $138.7M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding X4 Pharmaceuticals, Inc; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −51,592−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −32,337−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −14,746−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −12,890−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −11,532−100.0% | Sold out |
| 1620 Investment Advisors, Inc. | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −6,779−100.0% | Sold out |
| Pathstone Family Office, LLC | – | – | – | – | Not filed |